SHIV Fights Back to Evade Destruction by ECD4-Ig but Not Without Suffering Debilitating Wounds

Overview

Journal Mol Ther

Publisher Cell Press

Date 2025 Jan 22

PMID 39842428

Authors

Eric J Arts

Affiliations

Soon will be listed here.

References

Li Y, Migueles S, Welcher B, Svehla K, Phogat A, Louder M . Broad HIV-1 neutralization mediated by CD4-binding site antibodies. Nat Med. 2007; 13(9):1032-4. PMC: 2584972. DOI: 10.1038/nm1624. View

Anastassopoulou C, Marozsan A, Matet A, Snyder A, Arts E, Kuhmann S . Escape of HIV-1 from a small molecule CCR5 inhibitor is not associated with a fitness loss. PLoS Pathog. 2007; 3(6):e79. PMC: 1885273. DOI: 10.1371/journal.ppat.0030079. View

OHagan D, Shandilya S, Hopkins L, Hahn P, Fuchs S, Martinez-Navio J . In vivo evolution of env in SHIV-AD8-infected rhesus macaques after AAV-vectored delivery of eCD4-Ig. Mol Ther. 2024; 33(2):560-579. PMC: 11853013. DOI: 10.1016/j.ymthe.2024.12.015. View

Ratcliff A, Shi W, Arts E . HIV-1 resistance to maraviroc conferred by a CD4 binding site mutation in the envelope glycoprotein gp120. J Virol. 2012; 87(2):923-34. PMC: 3554087. DOI: 10.1128/JVI.01863-12. View

Fetzer I, Gardner M, Davis-Gardner M, Prasad N, Alfant B, Weber J . eCD4-Ig Variants That More Potently Neutralize HIV-1. J Virol. 2018; 92(12). PMC: 5974481. DOI: 10.1128/JVI.02011-17. View

Julg B, Barouch D . Broadly neutralizing antibodies for HIV-1 prevention and therapy. Semin Immunol. 2021; 51:101475. DOI: 10.1016/j.smim.2021.101475. View

Gardner M, Kattenhorn L, Kondur H, von Schaewen M, Dorfman T, Chiang J . AAV-expressed eCD4-Ig provides durable protection from multiple SHIV challenges. Nature. 2015; 519(7541):87-91. PMC: 4352131. DOI: 10.1038/nature14264. View

Ratcliff A, Venner C, Olabode A, Knapp J, Pankrac J, Derecichei I . Enhancement of CD4 Binding, Host Cell Entry, and Sensitivity to CD4bs Antibody Inhibition Conferred by a Natural but Rare Polymorphism in the HIV-1 Envelope. J Virol. 2022; 96(14):e0185121. PMC: 9327689. DOI: 10.1128/jvi.01851-21. View

Westby M, Smith-Burchnell C, Mori J, Lewis M, Mosley M, Stockdale M . Reduced maximal inhibition in phenotypic susceptibility assays indicates that viral strains resistant to the CCR5 antagonist maraviroc utilize inhibitor-bound receptor for entry. J Virol. 2006; 81(5):2359-71. PMC: 1865946. DOI: 10.1128/JVI.02006-06. View

10.

Gardner M, Fellinger C, Kattenhorn L, Davis-Gardner M, Weber J, Alfant B . AAV-delivered eCD4-Ig protects rhesus macaques from high-dose SIVmac239 challenges. Sci Transl Med. 2019; 11(502). PMC: 6716512. DOI: 10.1126/scitranslmed.aau5409. View